Hematology-Oncology

Get The App!

Featured Programs

Antibody-Drug Conjugates: A New Option for Patients With Metastatic Urothelial Carcinoma

New!

9 episodes

1.50 credit hours

Various Speakers

Implementing Data Into Practice: Late-Breaking Melanoma Highlights From the 2022 European...

6 episodes

0.75 credit hours

Various Speakers

Integrating Immune Checkpoint Therapy Into the Management of Resectable Melanoma

12 episodes

2.25 credit hours

Various Speakers

Selecting CAR T-cell Therapy for Patients With Late Relapsed Multiple Myeloma

10 episodes

1.50 credit hours

Various Speakers

Test Your Knowledge:

Risk Assessment In Everyday Management of PAH

See More Quizzes

Featured Areas of Interest

Anticoagulation Management & Reversal Show all (31)

Alternatives to Heparin...What Does the Future Hold?

2 episodes - non-certified

Various Speakers

Advanced Management of Life-Threatening Bleeding in the Anticoagulated Patient

6 episodes

1.00 credit hour

Various Speakers

Highlights from ISTH 2022

12 episodes - non-certified

Various Speakers

Looking Deep into Venous Thromboembolism - Addressing the Global Challenges

9 episodes

1.50 credit hours

Various Speakers

The Bleeding Patient in the Emergency Department, Evidence-Based Approaches

2 episodes - 0.50 credit hours Previously Certified

Natalie Kreitzer, MD, MS

Managing Intracranial Hemorrhages in the Presence of Anticoagulation

3 episodes - 0.50 credit hours Previously Certified

Fred Rincon, MD, MSc, MBE

Case Studies in Hemorrhagic Stroke Management - What Should be Done?

4 episodes - 0.50 credit hours Previously Certified

Anmar Razak, MD

Time is Brain: The Management of Hemorrhagic Strokes and Role of Comprehensive Stroke...

7 episodes - 1.00 credit hour Previously Certified

Various Speakers

Translating CAT Guidelines into Everyday Practice During COVID-19

8 episodes - 1.25 credit hours Previously Certified

Various Speakers

Redefining the Coordination for VTE - Site of Care, Clinicians, and Patients – Part 2

10 episodes - 1.00 credit hour Previously Certified

Various Speakers

Redefining the Coordination for VTE - Site of Care, Clinicians, and Patients

12 episodes - 1.50 credit hours Previously Certified

Various Speakers

Casual and Educational Debriefs with Anticoagulation Experts at ISTH 2020

5 episodes - 1.25 credit hours Previously Certified

Various Speakers

ISTH 2020 Roundtable Discussions - Anticoagulation and Hemophilia

8 episodes - non-certified

Various Speakers

Highlights From ISTH 2020

22 episodes - non-certified

Various Speakers

COVID-19 and Hypercoagulability: Does this Pose a Threat of CTEPH in Susceptible...

2 episodes - non-certified

Richard Channick, MD & Victor Tapson, MD

Management of Life-Threatening Bleeding in the Anticoagulated Patient in the Emergency...

9 episodes - 2.75 credit hours Previously Certified

Various Speakers

Integrating Health Economics into Clinical Practice for the Reversal of an Anticoagulated...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Holding Court in Anticoagulation Reversal

11 episodes - 2.00 credit hours Previously Certified

Various Speakers

Time is Brain: Managing Traumatic Brain Injuries for the Trauma Specialist

6 episodes - 1.75 credit hours Previously Certified

Various Speakers

2019 ASH Annual Meeting Highlights

11 episodes - non-certified

Various Speakers

Impacting Emergency Department Bleeds: The Change is Here and Now

9 episodes - 1.00 credit hour Previously Certified

Various Speakers

2019 ISTH Highlights in Thrombosis

29 episodes - non-certified

Various Speakers

Thrombosis

1 episodes - non-certified

Manesh R. Patel, MD

Updates in Bleeding Management and Reversal in the Emergency Room

4 episodes - 1.25 credit hours Previously Certified

Colin G. Kaide, MD, FACEP, FAAEM; Robert Takla, MD

Updates in Bleeding Management in Surgery and Trauma: Presented at the AAST Annual Meeting

4 episodes - 1.25 credit hours Previously Certified

Truman J. Milling Jr., MD, FACEP; Casey O'Connell, MD

Bleeding and DOACs

10 episodes - 1.25 credit hours Previously Certified

Jerrold H. Levy, MD, FAHA, FCCM

Highlights from THSNA 2018

5 episodes - non-certified

Various Speakers

Highlights from ISTH 2017

11 episodes - non-certified

Various Speakers

Highlights from AC Forum 2017

14 episodes - 1.75 credit hours Previously Certified

Various Speakers

Reversal Strategies for Patients Taking Novel Oral Anticoagulants (NOACs)

8 episodes - non-certified

Scott Kaatz, DO, MSc, FACP, SFHM et al.

Breaking the Barrier to Effective VTE Prevention in Medically Ill Patients

11 episodes - 1.00 credit hour Previously Certified

C. Michael Gibson, MS, MD

Immuno-Oncology Show all (41)

Integrating Immune Checkpoint Therapy Into the Management of Resectable Melanoma

12 episodes

2.25 credit hours

Various Speakers

Implementing Data Into Practice: Late-Breaking Melanoma Highlights From the 2022 European...

6 episodes

0.75 credit hours

Various Speakers

Moving Forward in Esophageal Cancer: The Expanding Role of Checkpoint Inhibitors

7 episodes - 1.25 credit hours Previously Certified

Various Speakers

The Evolving Role of Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Case Discussions in Advanced NSCLC: Selecting Frontline Immunotherapy

10 episodes - 1.50 credit hours Previously Certified

Various Speakers

Individualizing Patient Care Using Biomarker-Driven Cancer Immunotherapy

9 episodes - 1.50 credit hours Previously Certified

Various Speakers

Applying Evolving Treatment Strategies in Advanced Melanoma

7 episodes - 1.00 credit hour Previously Certified

Various Speakers

Highlights in GU Oncology from the 2021 Mid to Late Year Congresses: Implementing Data...

17 episodes - 2.50 credit hours Previously Certified

Various Speakers

Practice-Changing Highlights in Genitourinary Cancers - Data from the European Congress

5 episodes - 0.75 credit hours Previously Certified

Various Speakers

Practice-Changing Highlights in Advanced Melanoma - Data from the European Congress

3 episodes - 0.50 credit hours Previously Certified

Various Speakers

Practice-Changing Highlights in Gastric and Esophageal Cancers - Data from the European...

3 episodes - 0.50 credit hours Previously Certified

Various Speakers

Optimal Dosing of ICIs: A Look at Various Dosing Strategies Across Multiple Tumor Types

9 episodes - 2.25 credit hours Previously Certified

Various Speakers

Highlights in Upper GI Oncology from the 2021 Mid-Year Congress: Implementing Data into...

5 episodes

1.00 credit hour

Various Speakers

Latest Immunotherapy Advances in RCC: Integrating Data from the 2021 Winter Meeting into...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Immunotherapy Advances in Urothelial Cancer: Integrating Data from the Winter 2021...

7 episodes - 1.00 credit hour Previously Certified

Various Speakers

IO Advances in Upper Gl Cancers: Integrating Data from Fall 2020 Meetings into Clinical...

12 episodes - 2.00 credit hours Previously Certified

Various Speakers

Highlights in Hematologic Malignancies from the Winter 2020 Hematology Meeting -...

9 episodes - 1.25 credit hours Previously Certified

Various Speakers

Clinical Practice Implications and Highlights from the 62nd ASH Annual Meeting and...

6 episodes - non-certified

Various Speakers

The Evolving Role of Checkpoint Inhibitors as Frontline Treatment for Malignant Pleural...

7 episodes - 1.00 credit hour Previously Certified

Patrick Forde, MBBCh & Joshua Reuss, MD

IO On The GO Series: Clinical Questions and Latest Approaches in Hepatocellular Carcinoma...

5 episodes - 1.00 credit hour Previously Certified

Various Speakers

Advancing the Care of ß-thalassemia Patients with Novel Therapies

14 episodes - 1.75 credit hours Previously Certified

Various Speakers

Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice

12 episodes - 2.00 credit hours Previously Certified

Various Speakers

Ushering in Maintenance Therapy for AML

11 episodes - 1.75 credit hours Previously Certified

Various Speakers

Impacting Patient Outcomes in mRCC

9 episodes - 1.50 credit hours Previously Certified

Various Speakers

Changing the Treatment Paradigm for Patients with Intermediate- and Higher-Risk MDS

8 episodes - 1.25 credit hours Previously Certified

Various Speakers

Contemporary Challenges and New Approaches in Metastatic Melanoma

9 episodes - 1.75 credit hours Previously Certified

Various Speakers

Integrating and Optimizing Immunotherapy-Based Combinations in mccRCC

6 episodes - 1.25 credit hours Previously Certified

Various Speakers

Frontline Systemic Therapy for Metastatic Melanoma

7 episodes - 1.00 credit hour Previously Certified

Various Speakers

TKI’s and Immune Checkpoint Inhibitors: The New Foundation in Metastatic Clear-cell Renal...

13 episodes - 2.00 credit hours Previously Certified

Various Speakers

New and Emerging Approaches to Managing Lower-Risk MDS

10 episodes - 2.00 credit hours Previously Certified

Various Speakers

Highlights from the 2020 SOHO Meeting

10 episodes - non-certified

Various Speakers

Navigating First-Line Checkpoint Inhibitor Combinations in Non-Small Cell Lung Cancer...

12 episodes - 2.00 credit hours Previously Certified

Various Speakers

Advances in First-Line NSCLC: Integrating the Latest Congress Data into Clinical Practice

3 episodes - 0.50 credit hours Previously Certified

Various Speakers

Highlights from the 2020 Genitourinary Cancers Symposium - Immunotherapy in GU...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Defining the Role of Immune Checkpoint Inhibitor Therapy in Advanced Hepatocellular...

9 episodes - 1.50 credit hours Previously Certified

Various Speakers

Innovative Solutions to Managing Treatment Related Adverse Events

7 episodes - 1.50 credit hours Previously Certified

Various Speakers

Recognizing and Managing Immunotherapy Related Adverse Events

8 episodes - 1.25 credit hours Previously Certified

Various Speakers

Cardiopulmonary and Vascular Toxicities Associated with Targeted and Immunotherapies

10 episodes - 1.50 credit hours Previously Certified

Various Speakers

Highlights from Oncology Nursing Society (ONS) 2019 – “Growing Together, Transforming...

12 episodes - non-certified

Various Speakers

Highlights from Oncology Nursing Society (ONS) 2018 – “One Nurse. One Moment. One Action”

10 episodes - non-certified

Various Speakers

Highlights from Oncology Nursing Society (ONS) 2017 – “Elevate Your Passion”

16 episodes - non-certified

Various Speakers

Gastrointestinal Cancers (GI) Show all (24)

Alternatives to Heparin...What Does the Future Hold?

2 episodes - non-certified

Various Speakers

Targeting NRG1 Fusion Positive Tumors: An Actionable Oncogenic Driver to Outcomes

7 episodes

1.00 credit hour

Various Speakers

Highlights from ISTH 2022

12 episodes - non-certified

Various Speakers

Moving Forward in Esophageal Cancer: The Expanding Role of Checkpoint Inhibitors

7 episodes - 1.25 credit hours Previously Certified

Various Speakers

The Evolving Role of Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Individualizing Patient Care Using Biomarker-Driven Cancer Immunotherapy

9 episodes - 1.50 credit hours Previously Certified

Various Speakers

Practice-Changing Highlights in Gastric and Esophageal Cancers - Data from the European...

3 episodes - 0.50 credit hours Previously Certified

Various Speakers

Optimal Dosing of ICIs: A Look at Various Dosing Strategies Across Multiple Tumor Types

9 episodes - 2.25 credit hours Previously Certified

Various Speakers

Highlights in Upper GI Oncology from the 2021 Mid-Year Congress: Implementing Data into...

5 episodes

1.00 credit hour

Various Speakers

Highlights in GI Cancers Presented at ASCO 2021

3 episodes - non-certified

Various Speakers

IO Advances in Upper Gl Cancers: Integrating Data from Fall 2020 Meetings into Clinical...

12 episodes - 2.00 credit hours Previously Certified

Various Speakers

IO On The GO Series: Clinical Questions and Latest Approaches in Hepatocellular Carcinoma...

5 episodes - 1.00 credit hour Previously Certified

Various Speakers

Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice

12 episodes - 2.00 credit hours Previously Certified

Various Speakers

Highlights from the 2020 Gastrointestinal Cancers Symposium - Immunotherapy in GI...

10 episodes - 1.50 credit hours Previously Certified

Various Speakers

Defining the Role of Immune Checkpoint Inhibitor Therapy in Advanced Hepatocellular...

9 episodes - 1.50 credit hours Previously Certified

Various Speakers

Innovative Solutions to Managing Treatment Related Adverse Events

7 episodes - 1.50 credit hours Previously Certified

Various Speakers

Recognizing and Managing Immunotherapy Related Adverse Events

8 episodes - 1.25 credit hours Previously Certified

Various Speakers

Cardiopulmonary and Vascular Toxicities Associated with Targeted and Immunotherapies

10 episodes - 1.50 credit hours Previously Certified

Various Speakers

GI Weekly: Outcomes 365

20 episodes - non-certified

Various Speakers

Oncology Nursing Weekly

1 episodes - non-certified

Various Speakers

GI Weekly Special Edition: 2019 Gastrointestinal Cancers Symposium

8 episodes - non-certified

Various Speakers

IMPACT Live GI Oncology Flip Classroom Training

4 episodes - non-certified

Johanna Bendell, MD

GI Weekly Special Edition: ASCO 2018

5 episodes - non-certified

Various Speakers

Highlights in Gastrointestinal Cancers (GI) from ASCO 2017

7 episodes - non-certified

Various Speakers

Genitourinary Cancers (GU) Show all (21)

Antibody-Drug Conjugates: A New Option for Patients With Metastatic Urothelial Carcinoma

New!

9 episodes

1.50 credit hours

Various Speakers

2022 Spring & Summer Conference Coverage: Integrating Prostate Cancer Data into Clinical...

5 episodes

1.00 credit hour

Various Speakers

Androgen Deprivation Therapy in Prostate Cancer: Balancing the Risks and Benefits

9 episodes

1.50 credit hours

Various Speakers

Highlights in GU Oncology from the 2021 Mid to Late Year Congresses: Implementing Data...

17 episodes - 2.50 credit hours Previously Certified

Various Speakers

Practice-Changing Highlights in Genitourinary Cancers - Data from the European Congress

5 episodes - 0.75 credit hours Previously Certified

Various Speakers

Optimal Dosing of ICIs: A Look at Various Dosing Strategies Across Multiple Tumor Types

9 episodes - 2.25 credit hours Previously Certified

Various Speakers

Advances in Castrate-Resistant Prostate Cancer (CRPC): Integrating Data into Clinical...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Latest Immunotherapy Advances in RCC: Integrating Data from the 2021 Winter Meeting into...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Immunotherapy Advances in Urothelial Cancer: Integrating Data from the Winter 2021...

7 episodes - 1.00 credit hour Previously Certified

Various Speakers

Patient Care in Kidney Cancer: What You Need to Know Along Your Journey

15 episodes - non-certified

Various Speakers

Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice

12 episodes - 2.00 credit hours Previously Certified

Various Speakers

Impacting Patient Outcomes in mRCC

9 episodes - 1.50 credit hours Previously Certified

Various Speakers

Integrating and Optimizing Immunotherapy-Based Combinations in mccRCC

6 episodes - 1.25 credit hours Previously Certified

Various Speakers

Advances in Genitourinary Cancers: Integrating Data into Clinical Practice and COVID-19...

5 episodes - 1.00 credit hour Previously Certified

Various Speakers

TKI’s and Immune Checkpoint Inhibitors: The New Foundation in Metastatic Clear-cell Renal...

13 episodes - 2.00 credit hours Previously Certified

Various Speakers

Highlights from the 2020 Genitourinary Cancers Symposium - Immunotherapy in GU...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Innovative Solutions to Managing Treatment Related Adverse Events

7 episodes - 1.50 credit hours Previously Certified

Various Speakers

Recognizing and Managing Immunotherapy Related Adverse Events

8 episodes - 1.25 credit hours Previously Certified

Various Speakers

Cardiopulmonary and Vascular Toxicities Associated with Targeted and Immunotherapies

10 episodes - 1.50 credit hours Previously Certified

Various Speakers

Impacting Prostate Cancer Through New Approaches and Therapies

11 episodes - 1.50 credit hours Previously Certified

Daniel P. Petrylak, MD; Neal D. Shore, MD, FACS

Highlights from ASCO 2017

4 episodes - non-certified

Various

Bone Marrow/Stem Cell Transplantation Show all (15)

Applying Recent Evidence to the Management of Acute and Chronic GVHD

6 episodes

1.25 credit hours

Iskra Pusic, MD, MSCI and Mark A. Schroeder, MD

Highlights in Hematologic Malignancies from the Winter 2020 Hematology Meeting -...

9 episodes - 1.25 credit hours Previously Certified

Various Speakers

Clinical Practice Implications and Highlights from the 62nd ASH Annual Meeting and...

6 episodes - non-certified

Various Speakers

Advancing the Care of ß-thalassemia Patients with Novel Therapies

14 episodes - 1.75 credit hours Previously Certified

Various Speakers

Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice

12 episodes - 2.00 credit hours Previously Certified

Various Speakers

Ushering in Maintenance Therapy for AML

11 episodes - 1.75 credit hours Previously Certified

Various Speakers

Changing the Treatment Paradigm for Patients with Intermediate- and Higher-Risk MDS

8 episodes - 1.25 credit hours Previously Certified

Various Speakers

New and Emerging Approaches to Managing Lower-Risk MDS

10 episodes - 2.00 credit hours Previously Certified

Various Speakers

Highlights from the 2020 SOHO Meeting

10 episodes - non-certified

Various Speakers

SOHO 2019 Annual Meeting - Cellular Therapy

1 episodes - non-certified

Various Speakers

Innovative Solutions to Managing Treatment Related Adverse Events

7 episodes - 1.50 credit hours Previously Certified

Various Speakers

Cardiopulmonary and Vascular Toxicities Associated with Targeted and Immunotherapies

10 episodes - 1.50 credit hours Previously Certified

Various Speakers

SOHO 2019 Meeting - Next Questions

11 episodes - non-certified

Various

The Role of JAK Inhibition in Graft-Versus-Host Disease (GVHD)

5 episodes - 1.00 credit hour Previously Certified

Mark A. Schroeder, MD

Recent Advances in the Treatment of Adult and Pediatric Patients with Hepatic...

9 episodes - 1.25 credit hours Previously Certified

Various Speakers